Neuroone Medical Technologies (NMTC) Amortization of Deferred Charges (2016 - 2024)
Neuroone Medical Technologies' (NMTC) quarterly Amortization of Deferred Charges came in at $192647.0 in Q4 2024, down 71.49% quarter-over-quarter from $675632.0 in Q2 2018.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Amortization of Deferred Charges (2016 - 2024) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Amortization of Deferred Charges for 4 consecutive years, with $192647.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Amortization of Deferred Charges changed N/A year-over-year to $192647.0; the trailing twelve-month figure through Sep 2025 stood at $192647.0 (changed N/A YoY), and the FY2025 full-year result was $192647.0, up 90.12% from the prior year.
- Amortization of Deferred Charges slipped to $192647.0 in Q4 2024 per NMTC's latest filing, from $675632.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $192647.0 in Q4 2024 and bottomed at $192647.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 192,647.00 |
| Jun 30, 2018 | 675,632.00 |
| Mar 31, 2018 | 437,524.00 |
| Dec 31, 2017 | 157,210.00 |
| Sep 30, 2017 | 284,637.00 |
| Dec 31, 2016 | 27,555.00 |